Novartis and Alcon Agree to Pay $345 Million to Resolve Corruption Charges

On June 25, 2020, Novartis Hellas S.A.C.I. (Novartis Greece), a subsidiary of Novartis AG, a Swiss-based global pharmaceutical company, and Alcon Pte Ltd., a former subsidiary of Novartis AG and current subsidiary of multinational eye care company Alcon Inc., have agreed to pay more than $233 million in criminal monetary penalties to resolve the U.S. Department of Justice’s investigation into violations of the Foreign Corrupt Practices Act (FCPA).[1]